Pre-eclampsia causes: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{Sara.Zand}} {{Ochuko}}
{{CMG}}; {{AE}} {{Sara.Zand}} {{Ochuko}}
==Overview==
==Overview==
Common cause of [[preeclampsia]] include [[uteroplacental ischemia]] and [[genetic]] predisposition following The formation of [[atheromatous plaques]] and [[fibrinoid necrosis]] of the [[ spiral ]] [[vessel walls]], [[Oxidative stress]] in [[trophoblast cells]], [[Apoptosis]] in [[trophoblast cells]],[[Systemic inflammatory response]], [[Vasospasm]],[[Platelet]] aggreggation, [[Thrombin]] formation,Deposition of the [[fibrin]] in multiple [[organs]].
Common cause of [[preeclampsia]] include [[uteroplacental ischemia]] and [[genetic]] predisposition following The formation of [[atheromatous plaques]] and [[fibrinoid necrosis]] of the [[spiral]] [[vessel walls]], [[oxidative stress]] in [[trophoblast cells]], [[apoptosis]] in [[trophoblast cells]],[[systemic inflammatory response]], [[vasospasm]], [[platelet]] aggregation, [[thrombin]] formation, deposition of the [[fibrin]] in multiple [[organs]].


==Causes==
==Causes==
Common cause of [[preeclampsia]] include [[uteroplacental]] [[ischemia]] and [[genetic predisposition]] due to the following:<ref name="LyeBloise2013">{{cite journal|last1=Lye|first1=P.|last2=Bloise|first2=E.|last3=Dunk|first3=C.|last4=Javam|first4=M.|last5=Gibb|first5=W.|last6=Lye|first6=S.J.|last7=Matthews|first7=S.G.|title=Effect of oxygen on multidrug resistance in the first trimester human placenta|journal=Placenta|volume=34|issue=9|year=2013|pages=817–823|issn=01434004|doi=10.1016/j.placenta.2013.05.010}}</ref><ref name="MayrinkCosta2018">{{cite journal|last1=Mayrink|first1=J.|last2=Costa|first2=M. L.|last3=Cecatti|first3=J. G.|title=Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction|journal=The Scientific World Journal|volume=2018|year=2018|pages=1–9|issn=2356-6140|doi=10.1155/2018/6268276}}</ref>
Common cause of [[preeclampsia]] include [[uteroplacental]] [[ischemia]] and [[genetic predisposition]] due to the following:<ref name="LyeBloise2013">{{cite journal|last1=Lye|first1=P.|last2=Bloise|first2=E.|last3=Dunk|first3=C.|last4=Javam|first4=M.|last5=Gibb|first5=W.|last6=Lye|first6=S.J.|last7=Matthews|first7=S.G.|title=Effect of oxygen on multidrug resistance in the first trimester human placenta|journal=Placenta|volume=34|issue=9|year=2013|pages=817–823|issn=01434004|doi=10.1016/j.placenta.2013.05.010}}</ref><ref name="MayrinkCosta2018">{{cite journal|last1=Mayrink|first1=J.|last2=Costa|first2=M. L.|last3=Cecatti|first3=J. G.|title=Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction|journal=The Scientific World Journal|volume=2018|year=2018|pages=1–9|issn=2356-6140|doi=10.1155/2018/6268276}}</ref>
   
   
* The formation of [[atheromatous plaques]] and [[fibrinoid necrosis]] of the [[ spiral ]] [[vessel walls]]
* The formation of [[atheromatous plaques]] and [[fibrinoid necrosis]] of the [[spiral]] [[vessel walls]]
* [[Oxidative stress]] in [[trophoblast cells]]
* [[Oxidative stress]] in [[trophoblast cells]]
* [[Apoptosis]] in [[trophoblast cells]]
* [[Apoptosis]] in [[trophoblast cells]]
* [[Systemic inflammatory response]]
* [[Systemic inflammatory response]]
* [[Vasospasm]]
* [[Vasospasm]]
*[[Platelet]] aggreggation
* [[Platelet]] aggregation
* [[Thrombin]] formation
* [[Thrombin]] formation
* Deposition of the [[fibrin]] in multiple [[organs]]
* Deposition of the [[fibrin]] in multiple [[organs]]
Line 25: Line 25:
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Needs English Review]]

Revision as of 02:37, 28 January 2021

Pre-eclampsia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pre-eclampsia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pre-eclampsia causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pre-eclampsia causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pre-eclampsia causes

CDC on Pre-eclampsia causes

Pre-eclampsia causes in the news

Blogs on Pre-eclampsia causes

Directions to Hospitals Treating Pre-eclampsia

Risk calculators and risk factors for Pre-eclampsia causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Ogheneochuko Ajari, MB.BS, MS [3]

Overview

Common cause of preeclampsia include uteroplacental ischemia and genetic predisposition following The formation of atheromatous plaques and fibrinoid necrosis of the spiral vessel walls, oxidative stress in trophoblast cells, apoptosis in trophoblast cells,systemic inflammatory response, vasospasm, platelet aggregation, thrombin formation, deposition of the fibrin in multiple organs.

Causes

Common cause of preeclampsia include uteroplacental ischemia and genetic predisposition due to the following:[1][2]

References

  1. Lye, P.; Bloise, E.; Dunk, C.; Javam, M.; Gibb, W.; Lye, S.J.; Matthews, S.G. (2013). "Effect of oxygen on multidrug resistance in the first trimester human placenta". Placenta. 34 (9): 817–823. doi:10.1016/j.placenta.2013.05.010. ISSN 0143-4004.
  2. Mayrink, J.; Costa, M. L.; Cecatti, J. G. (2018). "Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction". The Scientific World Journal. 2018: 1–9. doi:10.1155/2018/6268276. ISSN 2356-6140.